Overview
Marc Maynadie practices practicing medicine in Dijon, France.
Mr. Maynadie is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Leukemia, and Chronic Lymphocytic Leukemia (CLL).
He is actively involved in clinical research, co-authoring 114 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marc Maynadie
Is Marc Maynadie a top-rated expert for Follicular Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Marc Maynadie is classified as an Distinguished expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marc Maynadie participate in research or clinical trials?
Yes. Marc Maynadie has published 114 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Marc Maynadie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Follicular LymphomaMr. Maynadie isDistinguished. Learn about Follicular Lymphoma.
- Advanced
- B-Cell LymphomaMr. Maynadie isAdvanced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Maynadie isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Maynadie isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hodgkin LymphomaMr. Maynadie isAdvanced. Learn about Hodgkin Lymphoma.
- LeukemiaMr. Maynadie isAdvanced. Learn about Leukemia.
- Non-Hodgkin LymphomaMr. Maynadie isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Small Lymphocytic Lymphoma (SLL)Mr. Maynadie isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Maynadie isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaMr. Maynadie isExperienced. Learn about Acute Myelomonocytic Leukemia.
- AnemiaMr. Maynadie isExperienced. Learn about Anemia.
- Chronic Myelogenous Leukemia (CML)Mr. Maynadie isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Maynadie isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Lymphofollicular HyperplasiaMr. Maynadie isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Mr. Maynadie isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Mr. Maynadie isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Multiple MyelomaMr. Maynadie isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Mr. Maynadie isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- SplenomegalyMr. Maynadie isExperienced. Learn about Splenomegaly.